_id
69109831ccc777a4e85d5bfe
Ticker
ERAS
Name
Erasca Inc
Exchange
NASDAQ
Address
3115 Merryfield Row, San Diego, CA, United States, 92121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.erasca.com
Description
Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in SEACRAFT-2 pivotal Phase 3 trial for patients with NRAS-mutated (NRASm) melanoma; and in SEACRAFT-1 Phase 1b trial for patients with NRAS Q61X melanoma. It also develops ERAS-0015, a pan-RAS molecular glue for the treatment of patients with RAS-altered solid tumors; ERAS-4001, a pan-KRAS inhibitor for the treatment of patients with KRAS-altered solid tumors; and ERAS-12, an investigational EGFR D2/D3 biparatopic antibody (bpAb) for the treatment of EGRF and RAS/MAPK solid tumors. In addition, the company's products under development include ERAS-801, a central nervous system (CNS)-penetrant EGFR inhibitor for patients with EGFR-altered recurrent glioblastoma (GBM) which is in phase 1 clinical trials; and ERAS-007, an oral inhibitor of ERK1/2 and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It has a license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Last Close
3.43
Volume
1068383
Current Price
3.435
Change
0.14577259475218346
Last Updated
2025-11-30T18:20:26.565Z
Image
-
Ipo Date
2021-07-16T00:00:00.000Z
Market Cap
899366464
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.674
Sentiment Sources
5
Rating
4.625
Target Price
5
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
34546000
Operating Income
-34546000
Interest Expense
-
Pretax Income
-30612000
Net Income
-30612000
Eps
-0.10790972427288809
Dividends Per Share
-
Shares Outstanding
283711805
Income Tax Expense
-
EBITDA
-29857000
Operating Margin
-
Total Other Income Expense Net
3934000
Cash
70230000
Short Term Investments
218170000
Receivables
2900000
Inventories
-
Total Current Assets
299925000
Property Plant Equipment
44118000
Total Assets
420401000
Payables
3029000
Short Term Debt
4885000
Long Term Debt
-
Total Liabilities
72515000
Equity
347886000
Depreciation
755000
Change In Working Capital
1256000
Cash From Operations
-21658000
Capital Expenditures
6000
Cash From Investing
25704000
Cash From Financing
41000
Net Change In Cash
4087000
PE
-
PB
2.8010503238129734
ROE
-8.799434297442266
ROA
-7.2816192159390685
FCF
-21664000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
34546000
Quarters > 0 > income Statement > operating Income
-34546000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-30612000
Quarters > 0 > income Statement > net Income
-30612000
Quarters > 0 > income Statement > eps
-0.10790972427288809
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
283681570
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-29857000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
3934000
Quarters > 0 > balance Sheet > cash
70230000
Quarters > 0 > balance Sheet > short Term Investments
218170000
Quarters > 0 > balance Sheet > receivables
2900000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
299925000
Quarters > 0 > balance Sheet > property Plant Equipment
44118000
Quarters > 0 > balance Sheet > total Assets
420401000
Quarters > 0 > balance Sheet > payables
3029000
Quarters > 0 > balance Sheet > short Term Debt
4885000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
72515000
Quarters > 0 > balance Sheet > equity
347886000
Quarters > 0 > cash Flow > net Income
-30612000
Quarters > 0 > cash Flow > depreciation
755000
Quarters > 0 > cash Flow > change In Working Capital
1256000
Quarters > 0 > cash Flow > cash From Operations
-21658000
Quarters > 0 > cash Flow > capital Expenditures
6000
Quarters > 0 > cash Flow > cash From Investing
25704000
Quarters > 0 > cash Flow > cash From Financing
41000
Quarters > 0 > cash Flow > net Change In Cash
4087000
Quarters > 0 > ratios > PE
-0.10790972427288809
Quarters > 0 > ratios > PB
2.8010503238129734
Quarters > 0 > ratios > ROE
-8.799434297442266
Quarters > 0 > ratios > ROA
-7.2816192159390685
Quarters > 0 > ratios > FCF
-21664000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
787000
Quarters > 1 > income Statement > gross Profit
-787000
Quarters > 1 > income Statement > operating Expenses
38125000
Quarters > 1 > income Statement > operating Income
-38125000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-33876000
Quarters > 1 > income Statement > net Income
-33876000
Quarters > 1 > income Statement > eps
-0.11955290263584929
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
283355730
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-29838000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
4249000
Quarters > 1 > balance Sheet > cash
66143000
Quarters > 1 > balance Sheet > short Term Investments
234518000
Quarters > 1 > balance Sheet > receivables
2100000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
310660000
Quarters > 1 > balance Sheet > property Plant Equipment
45639000
Quarters > 1 > balance Sheet > total Assets
445386000
Quarters > 1 > balance Sheet > payables
1663000
Quarters > 1 > balance Sheet > short Term Debt
4709000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
73128000
Quarters > 1 > balance Sheet > equity
372258000
Quarters > 1 > cash Flow > net Income
-33876000
Quarters > 1 > cash Flow > depreciation
787000
Quarters > 1 > cash Flow > change In Working Capital
159000
Quarters > 1 > cash Flow > cash From Operations
-20531000
Quarters > 1 > cash Flow > capital Expenditures
30000
Quarters > 1 > cash Flow > cash From Investing
15745000
Quarters > 1 > cash Flow > cash From Financing
447000
Quarters > 1 > cash Flow > net Change In Cash
-4339000
Quarters > 1 > ratios > PE
-0.11955290263584929
Quarters > 1 > ratios > PB
2.6146568577438227
Quarters > 1 > ratios > ROE
-9.100140225327594
Quarters > 1 > ratios > ROA
-7.60598671713974
Quarters > 1 > ratios > FCF
-20561000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
822000
Quarters > 2 > income Statement > gross Profit
-822000
Quarters > 2 > income Statement > operating Expenses
35630000
Quarters > 2 > income Statement > operating Income
-35630000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-30966000
Quarters > 2 > income Statement > net Income
-30966000
Quarters > 2 > income Statement > eps
-0.10931994777425366
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
283260289
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-34808000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
4664000
Quarters > 2 > balance Sheet > cash
70482000
Quarters > 2 > balance Sheet > short Term Investments
234103000
Quarters > 2 > balance Sheet > receivables
2500000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
314617000
Quarters > 2 > balance Sheet > property Plant Equipment
47112000
Quarters > 2 > balance Sheet > total Assets
471244000
Quarters > 2 > balance Sheet > payables
2262000
Quarters > 2 > balance Sheet > short Term Debt
4791000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
71742000
Quarters > 2 > balance Sheet > equity
399502000
Quarters > 2 > cash Flow > net Income
-30966000
Quarters > 2 > cash Flow > depreciation
822000
Quarters > 2 > cash Flow > change In Working Capital
-6138000
Quarters > 2 > cash Flow > cash From Operations
-31555000
Quarters > 2 > cash Flow > capital Expenditures
83000
Quarters > 2 > cash Flow > cash From Investing
34265000
Quarters > 2 > cash Flow > cash From Financing
33000
Quarters > 2 > cash Flow > net Change In Cash
2743000
Quarters > 2 > ratios > PE
-0.10931994777425366
Quarters > 2 > ratios > PB
2.435529966595912
Quarters > 2 > ratios > ROE
-7.751150181976561
Quarters > 2 > ratios > ROA
-6.5711181468623465
Quarters > 2 > ratios > FCF
-31638000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
4196000
Quarters > 3 > income Statement > cost Of Revenue
832000
Quarters > 3 > income Statement > gross Profit
-832000
Quarters > 3 > income Statement > operating Expenses
34880000
Quarters > 3 > income Statement > operating Income
-35712000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-32232000
Quarters > 3 > income Statement > net Income
-32232000
Quarters > 3 > income Statement > eps
-0.1378508565613937
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
233817916
Quarters > 3 > income Statement > income Tax Expense
-954724
Quarters > 3 > income Statement > EBITDA
-31400000
Quarters > 3 > income Statement > operating Margin
-851.0962821734985
Quarters > 3 > income Statement > total Other Income Expense Net
3480000
Quarters > 3 > balance Sheet > cash
67739000
Quarters > 3 > balance Sheet > short Term Investments
230570000
Quarters > 3 > balance Sheet > receivables
2300000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
308793000
Quarters > 3 > balance Sheet > property Plant Equipment
48539000
Quarters > 3 > balance Sheet > total Assets
502526000
Quarters > 3 > balance Sheet > payables
468000
Quarters > 3 > balance Sheet > short Term Debt
9238000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
79027000
Quarters > 3 > balance Sheet > equity
423499000
Quarters > 3 > cash Flow > net Income
-32232000
Quarters > 3 > cash Flow > depreciation
832000
Quarters > 3 > cash Flow > change In Working Capital
1126000
Quarters > 3 > cash Flow > cash From Operations
-24564000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
22617000
Quarters > 3 > cash Flow > cash From Financing
801000
Quarters > 3 > cash Flow > net Change In Cash
-1146000
Quarters > 3 > ratios > PE
-0.1378508565613937
Quarters > 3 > ratios > PB
1.8964969019053173
Quarters > 3 > ratios > ROE
-7.61087983678828
Quarters > 3 > ratios > ROA
-6.413996489733864
Quarters > 3 > ratios > FCF
-24564000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-5.8541468064823645
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
3805000
Annuals > 0 > income Statement > gross Profit
-3805000
Annuals > 0 > income Statement > operating Expenses
179587000
Annuals > 0 > income Statement > operating Income
-179587000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-161650000
Annuals > 0 > income Statement > net Income
-161650000
Annuals > 0 > income Statement > eps
-0.691349930601554
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
233817916
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-153282000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
17937000
Annuals > 0 > balance Sheet > cash
67739000
Annuals > 0 > balance Sheet > short Term Investments
230570000
Annuals > 0 > balance Sheet > receivables
2300000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
308793000
Annuals > 0 > balance Sheet > property Plant Equipment
48539000
Annuals > 0 > balance Sheet > total Assets
502526000
Annuals > 0 > balance Sheet > payables
468000
Annuals > 0 > balance Sheet > short Term Debt
9238000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
79027000
Annuals > 0 > balance Sheet > equity
423499000
Annuals > 0 > cash Flow > net Income
-161650000
Annuals > 0 > cash Flow > depreciation
3805000
Annuals > 0 > cash Flow > change In Working Capital
1735000
Annuals > 0 > cash Flow > cash From Operations
-109417000
Annuals > 0 > cash Flow > capital Expenditures
22560000
Annuals > 0 > cash Flow > cash From Investing
-156616000
Annuals > 0 > cash Flow > cash From Financing
240697000
Annuals > 0 > cash Flow > net Change In Cash
-25336000
Annuals > 0 > ratios > PE
-0.691349930601554
Annuals > 0 > ratios > PB
1.750187825047993
Annuals > 0 > ratios > ROE
-38.170101936486276
Annuals > 0 > ratios > ROA
-32.16748984132165
Annuals > 0 > ratios > FCF
-131977000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3732000
Annuals > 1 > income Statement > gross Profit
-3732000
Annuals > 1 > income Statement > operating Expenses
137793000
Annuals > 1 > income Statement > operating Income
-141525000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-125042000
Annuals > 1 > income Statement > net Income
-125042000
Annuals > 1 > income Statement > eps
-1.040733139158918
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
120147995
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-121310000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
16483000
Annuals > 1 > balance Sheet > cash
93075000
Annuals > 1 > balance Sheet > short Term Investments
219275000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
320676000
Annuals > 1 > balance Sheet > property Plant Equipment
60188000
Annuals > 1 > balance Sheet > total Assets
395297000
Annuals > 1 > balance Sheet > payables
2000000
Annuals > 1 > balance Sheet > short Term Debt
3970000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
78611000
Annuals > 1 > balance Sheet > equity
316686000
Annuals > 1 > cash Flow > net Income
-125042000
Annuals > 1 > cash Flow > depreciation
3732000
Annuals > 1 > cash Flow > change In Working Capital
813000
Annuals > 1 > cash Flow > cash From Operations
-101217000
Annuals > 1 > cash Flow > capital Expenditures
1775000
Annuals > 1 > cash Flow > cash From Investing
-91220000
Annuals > 1 > cash Flow > cash From Financing
1295000
Annuals > 1 > cash Flow > net Change In Cash
-191142000
Annuals > 1 > ratios > PE
-1.040733139158918
Annuals > 1 > ratios > PB
1.2026712394927468
Annuals > 1 > ratios > ROE
-39.48453673354679
Annuals > 1 > ratios > ROA
-31.63241815647475
Annuals > 1 > ratios > FCF
-102992000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
2641000
Annuals > 2 > income Statement > gross Profit
-2641000
Annuals > 2 > income Statement > operating Expenses
244809000
Annuals > 2 > income Statement > operating Income
-247450000
Annuals > 2 > income Statement > interest Expense
201359000
Annuals > 2 > income Statement > pretax Income
-242805000
Annuals > 2 > income Statement > net Income
-242805000
Annuals > 2 > income Statement > eps
-2.4872495743131333
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
97619878
Annuals > 2 > income Statement > income Tax Expense
-4645000
Annuals > 2 > income Statement > EBITDA
-240164000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
4645000
Annuals > 2 > balance Sheet > cash
284217000
Annuals > 2 > balance Sheet > short Term Investments
151403000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
444496000
Annuals > 2 > balance Sheet > property Plant Equipment
65233000
Annuals > 2 > balance Sheet > total Assets
514909000
Annuals > 2 > balance Sheet > payables
23049000
Annuals > 2 > balance Sheet > short Term Debt
2610000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
103056000
Annuals > 2 > balance Sheet > equity
-480971000
Annuals > 2 > cash Flow > net Income
-242805000
Annuals > 2 > cash Flow > depreciation
2641000
Annuals > 2 > cash Flow > change In Working Capital
15785000
Annuals > 2 > cash Flow > cash From Operations
-103264000
Annuals > 2 > cash Flow > capital Expenditures
16551000
Annuals > 2 > cash Flow > cash From Investing
-71081000
Annuals > 2 > cash Flow > cash From Financing
98075000
Annuals > 2 > cash Flow > net Change In Cash
-76270000
Annuals > 2 > ratios > PE
-2.4872495743131333
Annuals > 2 > ratios > PB
-0.6433964069767201
Annuals > 2 > ratios > ROE
50.48225360780587
Annuals > 2 > ratios > ROA
-47.15493417283442
Annuals > 2 > ratios > FCF
-119815000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
829000
Annuals > 3 > income Statement > gross Profit
-829000
Annuals > 3 > income Statement > operating Expenses
124054000
Annuals > 3 > income Statement > operating Income
-124883000
Annuals > 3 > income Statement > interest Expense
55861000
Annuals > 3 > income Statement > pretax Income
-122764000
Annuals > 3 > income Statement > net Income
-122764000
Annuals > 3 > income Statement > eps
-1.2884279805869743
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
95282004
Annuals > 3 > income Statement > income Tax Expense
27326000
Annuals > 3 > income Statement > EBITDA
-121935000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
2119000
Annuals > 3 > balance Sheet > cash
360487000
Annuals > 3 > balance Sheet > short Term Investments
53988000
Annuals > 3 > balance Sheet > receivables
100000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
420017000
Annuals > 3 > balance Sheet > property Plant Equipment
33310000
Annuals > 3 > balance Sheet > total Assets
501415000
Annuals > 3 > balance Sheet > payables
4677000
Annuals > 3 > balance Sheet > short Term Debt
570000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
44887000
Annuals > 3 > balance Sheet > equity
-238166000
Annuals > 3 > cash Flow > net Income
-122764000
Annuals > 3 > cash Flow > depreciation
829000
Annuals > 3 > cash Flow > change In Working Capital
7705000
Annuals > 3 > cash Flow > cash From Operations
-79600000
Annuals > 3 > cash Flow > capital Expenditures
18885000
Annuals > 3 > cash Flow > cash From Investing
-64590000
Annuals > 3 > cash Flow > cash From Financing
439397000
Annuals > 3 > cash Flow > net Change In Cash
295207000
Annuals > 3 > ratios > PE
-1.2884279805869743
Annuals > 3 > ratios > PB
-1.2682076899305526
Annuals > 3 > ratios > ROE
51.545560659372036
Annuals > 3 > ratios > ROA
-24.48351166199655
Annuals > 3 > ratios > FCF
-98485000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.10790972427288809
Valuation > metrics > PB
2.8010503238129734
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-8.799434297442266
Profitability > metrics > ROA
-10.206551637909477
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.20844472039691164
Risk > metrics > Interest Coverage
-45.75629139072848
Risk > final Score
-123
Risk > verdict
High
Liquidity > metrics > Current Ratio
37.89802880970432
Liquidity > metrics > Quick Ratio
37.89802880970432
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
22
Prev Risks > 1
23
Prev Risks > 2
-112
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:36:47.147Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.11
Earnings History > 0 > eps Estimate
-0.106
Earnings History > 0 > eps Difference
-0.004
Earnings History > 0 > surprise Percent
-3.7736
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.12
Earnings History > 1 > eps Estimate
-0.12
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
0
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.11
Earnings History > 2 > eps Estimate
-0.13
Earnings History > 2 > eps Difference
0.02
Earnings History > 2 > surprise Percent
15.3846
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.11
Earnings History > 3 > eps Estimate
-0.13
Earnings History > 3 > eps Difference
0.02
Earnings History > 3 > surprise Percent
15.3846
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.11
Earnings History > 4 > eps Estimate
-0.17
Earnings History > 4 > eps Difference
0.06
Earnings History > 4 > surprise Percent
35.2941
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-12
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.29
Earnings History > 5 > eps Estimate
-0.18
Earnings History > 5 > eps Difference
-0.11
Earnings History > 5 > surprise Percent
-61.1111
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-08
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.23
Earnings History > 6 > eps Estimate
-0.2
Earnings History > 6 > eps Difference
-0.03
Earnings History > 6 > surprise Percent
-15
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-27
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2
Earnings History > 7 > eps Estimate
-0.23
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
13.0435
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.2
Earnings History > 8 > eps Estimate
-0.22
Earnings History > 8 > eps Difference
0.02
Earnings History > 8 > surprise Percent
9.0909
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.21
Earnings History > 9 > eps Estimate
-0.24
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
12.5
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.22
Earnings History > 10 > eps Estimate
-0.31
Earnings History > 10 > eps Difference
0.09
Earnings History > 10 > surprise Percent
29.0323
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-1.06
Earnings History > 11 > eps Estimate
-0.32
Earnings History > 11 > eps Difference
-0.74
Earnings History > 11 > surprise Percent
-231.25
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-09
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.29
Earnings History > 12 > eps Estimate
-0.31
Earnings History > 12 > eps Difference
0.02
Earnings History > 12 > surprise Percent
6.4516
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.3
Earnings History > 13 > eps Estimate
-0.33
Earnings History > 13 > eps Difference
0.03
Earnings History > 13 > surprise Percent
9.0909
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.31
Earnings History > 14 > eps Estimate
-0.29
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-6.8966
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.26
Earnings History > 15 > eps Estimate
-0.34
Earnings History > 15 > eps Difference
0.08
Earnings History > 15 > surprise Percent
23.5294
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.46
Earnings History > 16 > eps Estimate
-0.32
Earnings History > 16 > eps Difference
-0.14
Earnings History > 16 > surprise Percent
-43.75
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-26
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-1.2
Earnings History > 17 > eps Estimate
-0.65
Earnings History > 17 > eps Difference
-0.55
Earnings History > 17 > surprise Percent
-84.6154
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-02
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.745
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.745
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.6752
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.6752
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2019-12-31
Earnings History > 20 > report Date
2020-03-31
Earnings History > 20 > date
2019-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.9555
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.9555
Earnings History > 20 > surprise Percent
-
Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in SEACRAFT-2 pivotal Phase 3 trial for patients with NRAS-mutated (NRASm) melanoma; and in SEACRAFT-1 Phase 1b trial for patients with NRAS Q61X melanoma. It also develops ERAS-0015, a pan-RAS molecular glue for the treatment of patients with RAS-altered solid tumors; ERAS-4001, a pan-KRAS inhibitor for the treatment of patients with KRAS-altered solid tumors; and ERAS-12, an investigational EGFR D2/D3 biparatopic antibody (bpAb) for the treatment of EGRF and RAS/MAPK solid tumors. In addition, the company's products under development include ERAS-801, a central nervous system (CNS)-penetrant EGFR inhibitor for patients with EGFR-altered recurrent glioblastoma (GBM) which is in phase 1 clinical trials; and ERAS-007, an oral inhibitor of ERK1/2 and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It has a license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APrice Action Confirms Reversal in Citiport Financial Services Limited Trend - Fibonacci Retracement Levels & Free Dynamic Capital Growth Bollywood Helpline
Read more →Indiana energy firm puts $13M behind bid for new natural gas power Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$5
Analyst Picks
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 74.96% of the total shares of Erasca Inc
1.
T. Rowe Price Investment Management,Inc.(7.1675%)
since
2025/06/30
2.
VR Adviser, LLC(6.295%)
since
2025/06/30
3.
BlackRock Inc(5.3464%)
since
2025/06/30
4.
Logos Global Management LP(5.2878%)
since
2025/06/30
5.
Suvretta Capital Management, LLC(5.1123%)
since
2025/06/30
6.
Vanguard Group Inc(4.4755%)
since
2025/06/30
7.
Paradigm Biocapital Advisors LP(4.1975%)
since
2025/06/30
8.
ARCH VENTURE CORP(3.8973%)
since
2025/06/30
9.
Siren, L.L.C.(3.0871%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(2.5833%)
since
2025/07/31
11.
Vivo Capital, LLC(2.3819%)
since
2025/06/30
12.
T. Rowe Price Small-Cap Value(2.0949%)
since
2025/07/31
13.
5AM Venture Management, LLC(1.9055%)
since
2025/06/30
14.
Geode Capital Management, LLC(1.7047%)
since
2025/06/30
15.
iShares Russell 2000 ETF(1.4896%)
since
2025/08/31
16.
Affinity Asset Advisors, LLC(1.4403%)
since
2025/06/30
17.
State Street Corp(1.4108%)
since
2025/06/30
18.
T. Rowe Price U.S. SC Value Eq Tr-D(1.3914%)
since
2025/06/30
19.
Millennium Management LLC(1.3389%)
since
2025/06/30
20.
T. Rowe Price US Small-Cap Core Equity(1.2597%)
since
2025/06/30
21.
T. Rowe Price Small-Cap Stock(1.2587%)
since
2025/07/31
22.
SILVERARC CAPITAL MANAGEMENT, LLC(0.9058%)
since
2025/06/30
23.
Vanguard Institutional Extnd Mkt Idx Tr(0.8066%)
since
2025/07/31
24.
Soleus Capital Management, L.P.(0.7622%)
since
2025/06/30
25.
Marshall Wace Asset Management Ltd(0.7313%)
since
2025/06/30
26.
Woodline Partners LP(0.7313%)
since
2025/06/30
27.
T. Rowe Price Instl Small-Cap Stock(0.6534%)
since
2025/07/31
28.
T. Rowe Price U.S. SC Core Eq Tr-D(0.6437%)
since
2025/06/30
29.
Goldman Sachs Group Inc(0.6415%)
since
2025/06/30
30.
Fidelity Small Cap Index(0.6194%)
since
2025/06/30
31.
T. Rowe Price US Smlr Coms Eq A(0.5561%)
since
2025/07/31
32.
iShares Russell 2000 Value ETF(0.5495%)
since
2025/08/31
33.
Fidelity Extended Market Index(0.4092%)
since
2025/07/31
34.
Schwab US Small-Cap ETF™(0.3515%)
since
2025/08/30
35.
iShares Biotechnology ETF(0.3384%)
since
2025/08/31
36.
Vanguard Russell 2000 ETF(0.2886%)
since
2025/07/31
37.
JPMorgan Small Cap Value I(0.2794%)
since
2025/07/31
38.
State St Russell Sm Cap® Indx SL Cl I(0.229%)
since
2025/08/31
39.
Vanguard Health Care ETF(0.1861%)
since
2025/07/31
40.
Schwab Small Cap Index(0.1539%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.11
EPS Estimate
-0.106
EPS Difference
-0.004
Surprise Percent
-3.7736%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.